$418 Million is the total value of Adamant Biomedical Investments AG's 101 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DNDNQ | Exit | DENDREON CORP | $0 | – | -50,000 | -100.0% | -0.02% | – |
| ONVO | Exit | ORGANOVO HLDGS INC | $0 | – | -50,000 | -100.0% | -0.08% | – |
| LDRH | Exit | LDR HLDG CORP | $0 | – | -33,000 | -100.0% | -0.26% | – |
| T107PS | Exit | WRIGHT MED GROUP INC | $0 | – | -38,000 | -100.0% | -0.29% | – |
| TNA | Exit | DIREXION SHS ETF TRdly smcap bull3x | $0 | – | -30,000 | -100.0% | -0.48% | – |
| RVNC | Exit | REVANCE THERAPEUTICS INC | $0 | – | -130,000 | -100.0% | -0.63% | – |
| PODD | Exit | INSULET CORP | $0 | – | -80,000 | -100.0% | -0.74% | – |
| V107SC | Exit | WELLPOINT INC | $0 | – | -38,000 | -100.0% | -1.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CELGENE CORPORATION | 2 | Q4 2014 | 5.0% |
| GILEAD SCIENCES INC | 2 | Q4 2014 | 5.2% |
| BIOGEN IDEC INC | 2 | Q4 2014 | 4.5% |
| AMGEN INC | 2 | Q4 2014 | 3.6% |
| ACTAVIS PLC | 2 | Q4 2014 | 3.2% |
| UNITEDHEALTH GROUP INCORPORATED | 2 | Q4 2014 | 2.8% |
| MYLAN INC | 2 | Q4 2014 | 2.7% |
| ALEXION PHARMACEUTICALS INC | 2 | Q4 2014 | 2.5% |
| AURIS MEDICAL HOLDING AG | 2 | Q4 2014 | 2.5% |
| MEDTRONIC INC | 2 | Q4 2014 | 2.3% |
View Adamant Biomedical Investments AG's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Auris Medical Holding AG | February 13, 2015 | 2,169,625 | 7.5% |
View Adamant Biomedical Investments AG's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2015-02-13 |
| SC 13G | 2015-02-13 |
| 13F-HR | 2014-11-14 |
| 13F-NT | 2014-08-07 |
| 13F-NT | 2014-04-29 |
| 13F-NT | 2014-02-03 |
| 13F-NT | 2013-10-31 |
| 13F-NT | 2013-07-24 |
| 13F-NT | 2013-05-13 |
| 13F-NT | 2013-02-14 |
View Adamant Biomedical Investments AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.